InspireMD Ltd.

168 articles with InspireMD Ltd.

• InspireMD Schedules Second Quarter 2017 Earnings Conference Call

  8/2/2017

• InspireMD Announces The Publication Of An Investigator Initiated Clinical Registry Reaffirming Mguard(TM) Prime As A Highly Effective Tool To Prevent Heart Damage In Coronary Artery Blockages With High Thrombotic Content

  6/8/2017

• InspireMD Announces Distribution Agreement For CGuard EPS In Taiwan

  6/8/2017

• InspireMD Announces Distribution Agreement For CGuard EPS In Poland

  6/7/2017

• InspireMD Announces Appointment Of Paul Stuka As Chairman Of The Board

  6/2/2017

• InspireMD Announces First Two Patients In Hong Kong Successfully Treated With CGuard EPS

  5/31/2017

• InspireMD Reports Financial Results For The Third Quarter Ended September 30, 2016

  11/15/2016

• InspireMD Announces CGuard Embolic Prevention System Commercialization Approval In Russia

  11/15/2016

• InspireMD To Report Third Quarter Financial Results On Monday, November 14, 2016

  11/7/2016

• InspireMD CGuard Embolic Prevention System 12-Month Clinical Trial Data Further Validate Potential Of CGuard To Improve Management of Carotid Artery Disease And Prevent Stroke

  11/2/2016

• Long-term Clinical Data On InspireMD's CGuard Embolic Prevention System To Be Presented At Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium

  10/27/2016

• InspireMD Announces Appointment Of Medical Device Industry Veteran Agustin Gago As Chief Commercial Officer

  10/26/2016

• InspireMD Announces Independent Study Published In The Journal Of Endovascular Therapy That Continues To Support The Clinical Benefit And Utility Of The CGuard Embolic Prevention System

  10/17/2016

• InspireMD To Present At The Dawson James Securities 2nd Annual Growth Stock Conference On October 20

  10/13/2016

• InspireMD Announces Adjustments To Shares Receivable Upon Warrant Exercise And Exercise Price Per Share

  10/7/2016

• InspireMD Announces 1-for-25 Reverse Stock Split

  9/29/2016

• InspireMD Appoints Thomas Kester To Board Of Directors

  9/7/2016

• InspireMD Reports Financial Results For The Second Quarter Ended June 30, 2016

  8/10/2016

• InspireMD To Report Second Quarter Financial Results On Tuesday, August 9, 2016

  8/3/2016

• UPDATE - InspireMD Announces Listing Of Warrants On The NYSE MKT

  8/1/2016